http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102153508-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9e6a0102f7dc0397aaeb636aa13eafb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68
filingDate 2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d04032ca25f50ff5fb597921fe488c8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429b76d56c5d402ad5906a837e70e2d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb599ff62880139ae65c16555de3113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90b6355bc786103181c55ab5c9c90cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_311aa61c5343c0c4787ec30fb62a9d77
publicationDate 2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102153508-A
titleOfInvention 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs
abstract The invention discloses 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumor drugs. The 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone compound can be obtained by Claisen-Schimidt reaction of aromatic aldehyde and N-cyclopropyl-4-piperidine ketone. The 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone compound can obviously restrain the proliferation of various tumor cells and can be used for preparing drugs for treating leukocythemia, colorectal cancer, lover cancer, skin cancer, gastric cancer, breast cancer, prostatic cancer or other malignant tumor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020047186-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021115017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106083704-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10875841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106083704-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11312676-B2
priorityDate 2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467329767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420166794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13182807

Total number of triples: 32.